GlassScriptPhysician profile
Billy M Knowles
NPI 1649208596
$6,996.58
in general payments reported to CMS, 2019-2025
39 companies · $1,343 in 2025
The $1,343 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,652 · 2022: $1,120 · 2023: $1,244 · 2024: $1,638 · 2025: $1,343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,225.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,071.31 | 2021-2025 | |
| Novo Nordisk INC | $961.28 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $669.62 | 2021-2025 | Jardiance, Zepbound, Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $491.64 | 2021-2025 | |
| Pfizer INC. | $480.19 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $419.78 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Biohaven Pharmaceuticals, INC. | $323.84 | 2021 | |
| Exact Sciences Corporation | $313.61 | 2023-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $305.95 | 2021-2025 | Trelegy Ellipta, Shingrix |
| Amgen INC. | $265.50 | 2021-2025 | Otezla, Repatha, Repatha |
| Astellas Pharma US INC | $176.91 | 2021-2024 | Veozah, Myrbetriq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $163.81 | 2023-2025 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $146.94 | 2021-2022 | |
| Abbott Laboratories | $123.47 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Merck Sharp & Dohme LLC | $99.39 | 2021-2022 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Billy Knowles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.